116 related articles for article (PubMed ID: 7903456)
21. Dopamine D1 receptors in the sub-commissural part of the globus pallidus and their role in oro-facial dyskinesia in cats.
Spooren WP; Piosik PA; Cools AR
Eur J Pharmacol; 1991 Nov; 204(2):217-22. PubMed ID: 1839622
[TBL] [Abstract][Full Text] [Related]
22. Stereoisomeric probes for the D1 dopamine receptor: synthesis and characterization of R-(+) and S-(-) enantiomers of 3-allyl-7,8-dihydroxy-1-phenyl-2,3,4,5-tetrahydro-1H-3-benzazepine and its 6-bromo analogue.
Neumeyer JL; Kula NS; Baldessarini RJ; Baindur N
J Med Chem; 1992 Apr; 35(8):1466-71. PubMed ID: 1533424
[TBL] [Abstract][Full Text] [Related]
23. Agonist efficacy and the behavioral effects of dopamine D1 receptor ligands: drug interaction studies in squirrel monkeys.
Bergman J; Spealman RD; Madras BK; Rosenzweig-Lipson S
J Pharmacol Exp Ther; 1996 Mar; 276(3):942-50. PubMed ID: 8786574
[TBL] [Abstract][Full Text] [Related]
24. Effects of monoamine oxidase inhibitors and dopamine agonists on the behavior of mammal- and frog-eating snakes.
Temple JG; Barthalmus GT
Physiol Behav; 1994 May; 55(5):927-33. PubMed ID: 7912837
[TBL] [Abstract][Full Text] [Related]
25. Dopamine D-1 receptor agonists combined with the selective D-2 agonist quinpirole facilitate the expression of oral stereotyped behaviour in rats.
Arnt J; Hyttel J; Perregaard J
Eur J Pharmacol; 1987 Jan; 133(2):137-45. PubMed ID: 2949991
[TBL] [Abstract][Full Text] [Related]
26. Repeated stimulation of D1 dopamine receptors causes time-dependent alterations in the sensitivity of both D1 and D2 dopamine receptors within the rat striatum.
Hu XT; Brooderson RJ; White FJ
Neuroscience; 1992 Sep; 50(1):137-47. PubMed ID: 1357592
[TBL] [Abstract][Full Text] [Related]
27. Failure of MK-801 to suppress D1 receptor-mediated induction of locomotor activity and striatal preprotachykinin mRNA expression in the dopamine-depleted rat.
Campbell BM; Kreipke CW; Walker PD
Neuroscience; 2006; 137(2):505-17. PubMed ID: 16289829
[TBL] [Abstract][Full Text] [Related]
28. Dopamine D1 antagonists potentiate the durations of bar and cling catalepsy and the dorsal immobility response in rats.
Meyer ME; Cottrell GA; Van Hartesveldt C
Pharmacol Biochem Behav; 1992 Mar; 41(3):507-10. PubMed ID: 1533938
[TBL] [Abstract][Full Text] [Related]
29. Role of the substantia nigra in the expression of dopamine D1 receptor-mediated and D2 receptor-mediated behaviours.
Fletcher GH; Starr MS
Neuroscience; 1987 Dec; 23(3):1001-10. PubMed ID: 2963970
[TBL] [Abstract][Full Text] [Related]
30. A68930 is a potent, full agonist at dopamine1 (D1) receptors in renal epithelial LLC-PK1 cells.
Grenader A; Healy DP
Br J Pharmacol; 1992 Jun; 106(2):229-30. PubMed ID: 1356555
[TBL] [Abstract][Full Text] [Related]
31. Behavioural stimulation is induced by separate dopamine D-1 and D-2 receptor sites in reserpine-pretreated but not in normal rats.
Arnt J
Eur J Pharmacol; 1985 Jul; 113(1):79-88. PubMed ID: 2931283
[TBL] [Abstract][Full Text] [Related]
32. The induction of grooming and vacuous chewing by a series of selective D-1 dopamine receptor agonists: two directions of D-1:D-2 interaction.
Murray AM; Waddington JL
Eur J Pharmacol; 1989 Feb; 160(3):377-84. PubMed ID: 2565818
[TBL] [Abstract][Full Text] [Related]
33. Dopamine D1 receptor stimulation but not dopamine D2 receptor stimulation attenuates haloperidol-induced behavioral supersensitivity and receptor up-regulation.
Marin C; Chase TN
Eur J Pharmacol; 1993 Feb; 231(2):191-6. PubMed ID: 8095897
[TBL] [Abstract][Full Text] [Related]
34. Thienopyridine derivatives identified as the first selective, full efficacy, dopamine D1 receptor agonists.
Andersen PH; Nielsen EB; Scheel-Krüger J; Jansen JA; Hohlweg R
Eur J Pharmacol; 1987 Jun; 137(2-3):291-2. PubMed ID: 2956116
[No Abstract] [Full Text] [Related]
35. Selective dopamine D-1 receptor agonists, SK&F 38393 and CY 208-243 reduce sucrose sham-feeding in the rat.
Cooper SJ; Francis J; Barber DJ
Neuropharmacology; 1993 Jan; 32(1):101-2. PubMed ID: 8094232
[TBL] [Abstract][Full Text] [Related]
36. Stereotyped behaviour in response to the selective D-2 dopamine receptor agonist RU 24213 is enhanced by pretreatment with the selective D-1 agonist SK&F 38393.
Mashurano M; Waddington JL
Neuropharmacology; 1986 Aug; 25(8):947-9. PubMed ID: 3490631
[TBL] [Abstract][Full Text] [Related]
37. Role of dopamine D1 receptors in the lethal effects of cocaine and a quaternary methiodide analog.
Witkin JM; Newman AH; Nowak G; Katz JL
J Pharmacol Exp Ther; 1993 Oct; 267(1):266-74. PubMed ID: 7901394
[TBL] [Abstract][Full Text] [Related]
38. Repeated stimulation of dopamine D1 receptors enhances the effects of dopamine receptor agonists.
White FJ; Hu XT; Brooderson RJ
Eur J Pharmacol; 1990 Dec; 191(3):497-9. PubMed ID: 1982272
[No Abstract] [Full Text] [Related]
39. Super-stereotypy II: enhancement of a complex movement sequence by intraventricular dopamine D1 agonists.
Berridge KC; Aldridge JW
Synapse; 2000 Sep; 37(3):205-15. PubMed ID: 10881042
[TBL] [Abstract][Full Text] [Related]
40. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
